Analysts expect revenue increase Astrazeneca

Tomorrow the English Astrazeneca will publish its past quarter figures. Over the current book year the company from Cambridge's total revenue could be around 43.11 billion GBp (consensus estimates). This is hugely more than 2021's revenue of 37.42 billion GBp.

Historical revenues and results Astrazeneca plus estimates 2021

The analysts expect for 2021 a net profit of 10.05 billion GBp. For this year the consensus of Astrazeneca 's result per share is a profit of 666 GBp. Based on this the price/earnings-ratio is 15.78.

Per share the analysts expect a dividend of 291 GBp per share. Thus the dividend yield equals 2.77 percent. The average dividend yield of the pharmaceutical companies equals a limited 1.37 percent.

Most recent target prices around 11230 GBp

The most recent recommendations for the pharmaceutical company are from Barclays , Jefferies & Co. and Morgan Stanley .

Astrazeneca 's market value equals around 13798.77 billion . 44

At 9.03 the stock trades 0.25 percent higher at 10512 GBp.

Historical stock prices Astrazeneca period 2007-2021

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.